参考文献/References:
[1] YU A S,KEEFE E B. Nonalcoholic fatty liver disease[J]. Rev Gastroenterol Disord,2002(2):11-19.
[2] PAPANDIEOU D,ROUSSO I. Update on non-alcoholic fatty liver disease in children[J]. Clin Nutr,2007(26):409-415.
[3] MADHUSUDANA G. The blind men “see” the elephant-the many faces of fatty liver disease[J]. World journal of gastroenterol,2008,14(6):831-844.
[4] UNGER R H,ORIC I. Lipoapoptosis:its mechanism and its diseases[J]. Biochem Biophy Acta,2002,1 585:202-212.
[5] DONNELY K L,SMITH C L. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalholic fatty liver disease[J]. Clin Invest,2005,115:1 343-1 351.
[6] LEWIS G F,CARPENTIER A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes[J]. Endocr Rev,2002,23:201-229.
[7] HOWARD C T. Non-alcoholic fatty liver disease:a massive problem[J]. Clinical medicine,2011,11(2):176-178.
[8] ADAMS L A,LINDOR K D. Nonalcoholic fatty liver disease[J]. CMAJ,2005,172(7):899-905.
[9] NEUSCHWANDER-TETRI B A,CALDWELL S H. Nonalcoholic steatohepatitis summary of an AASLD single topic conference[J]. Hepatology,2003,37:1 202-1 219.
[10] MATTEONI C A,YOUNOSSI Z M,GRAMLICH T. Nonalcoholic fatty liver disease:a spectrum of clinical and pathological severity[J]. Gastroenterology,1999,116:1 413-1 419.
[11] BUGIANESI E,MCCULLOUGH A J,MARCHESINI G. Insulin resistance:a metabolic pathway to chronic liver disease[J]. Hepatology,2005,42:987-1 000.
[12] 刘民力,张丹,丁晓红,等. 肝原性糖尿病血浆中氨基酸谱改变及分析[J]. 临床肝胆病杂志,2000,16(2):116-117.
[13] 马乃诚,李荣,张和顺. 糖尿病患者血浆游离氨基酸的改变[J]. 天津医药,1999,12(27):723-724.
[14] BAU J I,LLAYMAN D K. A reduced carbohydrate,increased protein diet stabilizes glycemic control and minimizes adipose tissue glucose disposal in rats[J]. Nutr,2006,136:1 855-1 861.
[15] HARRIS R A,JOSHI M. Mechanisms responsible for regulation of branched-chain amino acid catabolism[J]. Biochem Bionphys Res Commun,2004,313:391-396.
[16] ROSE H M,YOSHIMURA N. Plasma amino acid patterns in hepatic encephalophathy of differing etilology[J]. Gastroenterology,1977,72:483-489.
[17] 杨芊,李兰娟. 慢性重型肝炎患者氨基酸谱研究[J]. 浙江医学,2000,22:586-588.
[18] 杨艳玲,孙芳. 尿素循环障碍的临床和实验室筛查研究[J]. 中国儿科杂志,2005,43(5):331-334.
[19] 陈文,张静. 牛磺酸对高胆固醇血症大鼠胆固醇/胆汁酸代谢的影响[J]. 中国食品学报,2009,9(6):21-25.
[20] CHRISTOPHER L G,ANGELA M N. Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease[J]. Am J Physiol Regal Integr Comp Physiol,2011,301:R1710-R1722.
[21] CALAMITA Y Y,CHOU C H. Preventive effects of taurine on development of hepatic steatosis induced by a high-fat/cholesterol daietary habit[J]. Agtic Food Chem,2011,59:450-457.
相似文献/References:
[1]叶 春,何执静.长期游泳运动对非酒精性脂肪肝大鼠血清氨基酸谱的影响及分析[J].南京师范大学学报(自然科学版),2015,38(02):122.
Ye Chun,He Zhijing.Effect of Long-Term Exercise on Aminogram in Serum in a Rat Model of Non-Alcoholic Fatty Liver Disease[J].Journal of Nanjing Normal University(Natural Science Edition),2015,38(01):122.
[2]徐 琳,王金之,郑益丽,等.小鼠过度训练模型肌肉特异性microRNAs在循环和不同组织中的变化研究[J].南京师范大学学报(自然科学版),2019,42(04):103.[doi:10.3969/j.issn.1001-4616.2019.04.015]
Xu Lin,Wang Jinzhi,Zheng Yili,et al.Changes of Muscle-Specific microRNAs in Circulation andDifferent Tissues in the Mouse Overtraining Model[J].Journal of Nanjing Normal University(Natural Science Edition),2019,42(01):103.[doi:10.3969/j.issn.1001-4616.2019.04.015]